# OnCo record humanigen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/humanigen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "humanigen" ;
  schema:name "Humanigen"@en ;
  schema:alternateName "KaloBios Pharmaceuticals"@en, "Humanigen, Inc."@en, "NASDAQ:HGEN"@en ;
  schema:description "Humanigen, formerly KaloBios, made lenzilumab, an antibody that neutralises GM-CSF to blunt the cytokine storms of CAR-T therapy and COVID-19, before filing for bankruptcy in 2024."@en ;
  schema:url <https://onco.cc/companies/humanigen/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/lenzilumab/> .